“The sea has never been friendly to man,” wrote sailor-cum-author Joseph Conrad. That has often been true of cruise stocks, as well, but Viking Holdings looks like an exception.

Viking Therapeutics has a weight-loss drug candidate VK2735, that aims to compete with Eli Lilly's Zepbound. Shares of this small-cap biotech are likely to remain volatile, but have significant ...

Archaeologists found some unique silver treasures at a Viking Age site in Sweden, then cleaned and restored the artifacts, photos show. Photo from Arkeologerna, SHM Sifting through the stony soil ...

Viking experts from the Universities of Nottingham and Leicester have examined pregnancy in the Viking Age and discovered that pregnant women were depicted in art and literature with martial gear ...

These are some of the realities uncovered by the first interdisciplinary study to focus on pregnancy in the Viking age, authored by myself, Kate Olley, Brad Marshall and Emma Tollefsen as part of ...

A printable version of the full schedule is available at the link below. Buffalo Bills printable 2025 schedule NFL DRAFT GRADES: Recap all NFL Draft picks, grades and analysis for all 32 teams.

Pregnancy has perhaps been particularly overlooked in periods we mostly associate with warriors, kings and battles—such as the highly romanticized Viking age (the period from AD 800 until AD 1050).

I rate Altimmune a 'Strong Buy' and Viking Therapeutics a 'Buy' for high-risk, long-term investors. ALT's Pemvidutide stands out for its lean mass protection, visceral fat reduction, and potential ...

Pregnancy has perhaps been particularly overlooked in periods we mostly associate with warriors, kings and battles – such as the highly romanticised Viking age (the period from AD800 until AD1050).

Management remains optimistic that these trends will continue. In light of these achievements, Viking Therapeutics has large shoes to fill. The company's current $3 billion valuation is tiny ...

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand names ...